GB1155730A - Method of Producing Antitoxins - Google Patents

Method of Producing Antitoxins

Info

Publication number
GB1155730A
GB1155730A GB4760166A GB4760166A GB1155730A GB 1155730 A GB1155730 A GB 1155730A GB 4760166 A GB4760166 A GB 4760166A GB 4760166 A GB4760166 A GB 4760166A GB 1155730 A GB1155730 A GB 1155730A
Authority
GB
United Kingdom
Prior art keywords
milk
protein
remaining
water
antitoxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4760166A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNE MILK Co OF AMERICA
Original Assignee
IMMUNE MILK Co OF AMERICA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNE MILK Co OF AMERICA filed Critical IMMUNE MILK Co OF AMERICA
Publication of GB1155730A publication Critical patent/GB1155730A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1,155,730. Antitoxins. IMMUNE MILK CO. OF AMERICA, Inc. 24 Oct., 1966 [24 Oct., 1965], No. 47601/66. Heading A5B. Antitoxins are produced through the milk systems of female members of the equine, bovine, canine, porcine, hircine and camel species by a method including the steps of Iryper-immunizing said animal with a commercial toxoid, collecting the milk from the hyper-immunized animal, removing casein from the milk, concentrating the protein from the remaining milk serium of filtration, precipitation and centrifuging, emulsifying the concentrated residue with water, removing salt from the emulsion by dialysis, and collecting and freeze drying the remaining protein antitoxin. The collected milk may be diluted with sterile distilled water, the centrifuged sediment recovered in a sterile container, filtered, refrigerated and collected prior to emulsification with water. The animals may be given 5 cc. of commercial toxoid e.g. tetanus toxoid, at weekly intervals for a total of 8 weeks to produce hyper-immunization. Concentrated rennet may be thoroughly mixed with the diluted milk heated to about 100‹F. in the proportion of 5 parts by volume per 100,000 parts of dilute milk, said mixture is cooled to about 80‹F., permitted to coagulate for about one hour, agitated to break up the clots which have formed, and milk serum is withdrawn from the coagulated casein. Protein is precipitated from the milk serum by filtering the serum through multiple layers of cheese-cloth adjusting the pH to 6.8, adding ammonium sulphate, mixing thoroughly and holding: at about 40‹F.. for about 12 hours, siphoning off and discarding the clear supernatant liquid centrifuging at 20,000g the remaining precipitated protein solution, discarding the clear supernatant solution, placing the sediment on filter paper to absorb the remaining fluid, refrigerating for about 12 hours at -20‹F., recovering from the filter paper, emulsifying with water in the proportion of 10 gms of protein to 5 cc. of water, dialyzing against sterile distilled water for about 72 hours and freeze drying the remaining protein antitoxin. Antitoxins which may be produced by the above method include tetanus, diphtheria, staphylococcus, shigilla and botulinum, snake venom and toxins produced by micro-organisms such as bacteria e.g. Rickettsia, viruses, moulds and fungi.
GB4760166A 1965-10-24 1966-10-24 Method of Producing Antitoxins Expired GB1155730A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50502365A 1965-10-24 1965-10-24

Publications (1)

Publication Number Publication Date
GB1155730A true GB1155730A (en) 1969-06-18

Family

ID=24008683

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4760166A Expired GB1155730A (en) 1965-10-24 1966-10-24 Method of Producing Antitoxins

Country Status (4)

Country Link
JP (1) JPS5136326B1 (en)
CH (1) CH488013A (en)
DE (1) DE1617538C3 (en)
GB (1) GB1155730A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5314521U (en) * 1976-07-20 1978-02-07
SE448344B (en) * 1978-02-06 1987-02-16 Stolle Res & Dev ANTIBODY FOR TREATMENT OF REUMATOID ARTHRIT AND SETTING TO MAKE IT

Also Published As

Publication number Publication date
CH488013A (en) 1970-03-31
DE1617538A1 (en) 1971-04-08
JPS5136326B1 (en) 1976-10-07
DE1617538C3 (en) 1979-10-04
DE1617538B2 (en) 1979-02-08

Similar Documents

Publication Publication Date Title
US5707678A (en) Method for microfiltration of milk or colostral whey
US4402938A (en) Food and the method of extracting the same from colostrum and milk
US4051235A (en) Method of preparing bovine colostrum for use in treating livestock
CN101501059B (en) Method for extraction of one or several proteins present in milk
KR101645957B1 (en) Process for producing milk fractions rich in secretory immunoglobulins
ES468808A1 (en) Process for the production of a protein concentrate containing immunological factors of lactic origin
US20050220953A1 (en) Process of isolating lactoferrin
US5670196A (en) Method for microfiltration of milk or colostral whey
US6426109B1 (en) Method of treating colostrum
Seibert The chemical composition of the active principle of tuberculin. XI. An improved and simplified method for making a standard undenatured tuberculin of any desired strength and a method of chemical assay.
IE861576L (en) Separating alpha-lactalbumin from whey proteins dna segment conferring high frequency transduction of¹recombinant dna vectors
GB1155730A (en) Method of Producing Antitoxins
JP3929085B2 (en) Method for producing ganglioside-rich composition
Wang et al. Manufacturing technologies of whey protein products
EP2730170A1 (en) Food compositions free of allergens
US6521277B1 (en) Process for the preparation of colostrum
Gesan-Guiziou Integrated membrane operations in whey processing
Osborne THE PROTEINS OF COW'S MILK.* BY THOMAS B. OSBORNE AND ALFRED J. WAKEMAN. WITH THE COOPERATION OF CHARLES S. LEAVENWORTH AND OWEN L. NOLAN.
Wright et al. Purification of recombinant proteins from sheep's milk
EP1041081A2 (en) Method of manufacturing composition with high ganglioside content
GB2132466A (en) Whey product and method for obtaining same
US2123198A (en) Treatment of antitoxins and the like
JPH09110896A (en) Purification of component 3 of cow milk proteose peptone
Blackwell Potential transmission of foot-and-mouth disease in whey constituents
RU1417244C (en) Method of preparing of substance recovering prostate gland function